Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Usui

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Frontiers in Cell and Developmental Biology|December 17, 2020
NAD+ Metabolism Regulates Preadipocyte Differentiation by Enhancing α-Ketoglutarate-Mediated Histone H3K9 Demethylation at the PPARγ PromoterKeisuke Okabe, Allah Nawaz, Yasuhiro Nishida, et al.
The American Journal of the Medical Sciences|June 17, 2020
Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 DiabetesYoshimasa Aso, Masato Kase, Masaaki Sagara, et al.
Endocrinology|March 27, 2004
Impact of Src homology 2-containing inositol 5'-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acidsShihou Murakami, Toshiyasu Sasaoka, Tsutomu Wada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 25, 2019
Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)　- A 3-Month Interim Analysis of a Postmarketing Observational StudyMasato Nakamura, Ken Kozuma, Takanari Kitazono, et al.
Endocrine Journal|February 21, 2018
Concurrent variant type 3 autoimmune polyglandular syndrome and pulmonary arterial hypertension in a Japanese womanToshie Iijima, Takafumi Niitani, Seiichi Tanaka, et al.
Endocrine Journal|May 13, 2021
Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomyToshie Iijima, Teruo Jojima, Soichiro Hosonuma, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|May 21, 2021
Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver diseaseYoshimasa Aso, Masaaki Sagara, Takafumi Niitani, et al.
Expert Opinion on Pharmacotherapy|May 29, 2024
Empagliflozin increases plasma levels of citrulline, histidine, and α-aminobutyric acid in patients with type 2 diabetes: effects of a sodium-glucose co-transporter 2 inhibitor on the plasma amino acid profileTeruo Jojima, Shintaro Sakurai, Haruka Kishi, et al.
The EMBO Journal|July 9, 2004
GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulationIsao Usui, Takeshi Imamura, Hiroaki Satoh, et al.
The Journal of Clinical Investigation|July 16, 2004
Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal ratsHiroaki Satoh, M T Audrey Nguyen, Philip D G Miles, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Frontiers in Cell and Developmental Biology|December 17, 2020
NAD+ Metabolism Regulates Preadipocyte Differentiation by Enhancing α-Ketoglutarate-Mediated Histone H3K9 Demethylation at the PPARγ PromoterKeisuke Okabe, Allah Nawaz, Yasuhiro Nishida, et al.
The American Journal of the Medical Sciences|June 17, 2020
Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 DiabetesYoshimasa Aso, Masato Kase, Masaaki Sagara, et al.
Endocrinology|March 27, 2004
Impact of Src homology 2-containing inositol 5'-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acidsShihou Murakami, Toshiyasu Sasaoka, Tsutomu Wada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 25, 2019
Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)　- A 3-Month Interim Analysis of a Postmarketing Observational StudyMasato Nakamura, Ken Kozuma, Takanari Kitazono, et al.
Endocrine Journal|February 21, 2018
Concurrent variant type 3 autoimmune polyglandular syndrome and pulmonary arterial hypertension in a Japanese womanToshie Iijima, Takafumi Niitani, Seiichi Tanaka, et al.
Endocrine Journal|May 13, 2021
Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomyToshie Iijima, Teruo Jojima, Soichiro Hosonuma, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|May 21, 2021
Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver diseaseYoshimasa Aso, Masaaki Sagara, Takafumi Niitani, et al.
Expert Opinion on Pharmacotherapy|May 29, 2024
Empagliflozin increases plasma levels of citrulline, histidine, and α-aminobutyric acid in patients with type 2 diabetes: effects of a sodium-glucose co-transporter 2 inhibitor on the plasma amino acid profileTeruo Jojima, Shintaro Sakurai, Haruka Kishi, et al.
The EMBO Journal|July 9, 2004
GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulationIsao Usui, Takeshi Imamura, Hiroaki Satoh, et al.
The Journal of Clinical Investigation|July 16, 2004
Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal ratsHiroaki Satoh, M T Audrey Nguyen, Philip D G Miles, et al.
Pageof 9